由买买提看人间百态

topics

全部话题 - 话题: vosaroxin
(共0页)
f**********g
发帖数: 2252
1
来自主题: _pennystock版 - 有没有人来分析下SNSS?
SNSS correction around 3. Not bad today.
Sunesis posts net income in Q1
45 minutes ago - DTM via Comtex
DatamonitorSunesis Pharmaceuticals, Inc., a developer of new oncology
therapeutics, has reported a net income of $1.84 million, or $0.04 per share
, for the first quarter ended March 31, 2011, compared to a net loss of $4.
65 million, or $0.65 per share, for the first quarter ended March 31, 2010.
For the first quarter of 2011, total revenues were $4 million, compared to $
13,000 for the first... 阅读全帖
f**********g
发帖数: 2252
2
来自主题: _pennystock版 - 明天反弹,关注稀土,金银,和生拉.
Investors Hopeful for Blockbusters From BioSante and Sunesis
1 hours 15 minutes ago - Marketwire via Comtex
MarketwireRecent studies have shown that the chances of FDA approval for
early stage drugs is dropping significantly. Although it remains an exciting
time in the biotech sector with several potential blockbusters working
their way through the regulatory process, now, more than ever, many analysts
are urging investors to use caution. The Bedford Report examines the
outlook for companies in ... 阅读全帖
y*****l
发帖数: 5997
3
来自主题: _pennystock版 - 是不是应该SHort EXEL
snss要破2了。
At ASCO on Monday, Sunesis unveiled the design for a Phase III clinical
trial for its drug vosaroxin in the treatment of acute myeloid leukemia.
Sunesis said an interim analysis is expected mid-2012.
(共0页)